EMMA SULLIVAN: Open Payments
NPI 1447924055 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,246 in 161 payments from 21 companies in 2025. Trend: 2023 $2,411 · 2024 $3,976 · 2025 $3,246
Food & beverage: $3,246
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 62 | $1,474 |
| Supernus Pharmaceuticals, Inc. | 15 | $252 |
| Teva Pharmaceuticals USA, Inc. | 11 | $223 |
| Collegium Pharmaceutical, Inc. | 16 | $217 |
| PFIZER INC. | 12 | $159 |
| CATALYST PHARMACEUTICALS, INC. | 11 | $143 |
| Neurelis, Inc. | 5 | $131 |
| SK Life Science, Inc. | 3 | $73 |
| UCB, Inc. | 2 | $70 |
| Tris Pharma Inc | 4 | $70 |
Products named: UBRELVY, QULIPTA, Qelbree, AUSTEDO XR, Jornay PM, NURTEC ODT, FYCOMPA, VALTOCO.
Industry payments across NY — which companies pay providers there.
